How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption of PFO closure excluded patients over the age of 60 years. Older patients frequently have...
Enregistré dans:
Auteurs principaux: | Carlos Vazquez-Sosa, Stacey D Clegg, James C Blankenship |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Radcliffe Medical Media
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b323103fa1b54065adbaba5e98ebeea0 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Patent Foramen Ovale Closure in 2019
par: Joel P Giblett, et autres
Publié: (2019) -
Patent Foramen Ovale Closure: State of the Art
par: Joel P Giblett, et autres
Publié: (2020) -
Percutaneous closure of the patent foramen ovale: A cardiological perspective
par: S.C. Brown
Publié: (2017) -
Long-term follow-up outcomes in a real-world study cohort after percutaneous patent foramen ovale closure
par: Ahmet Hakan Ateş, et autres
Publié: (2021) -
Atrial fibrillation screening on systematic ambulatory electrocardiogram monitoring after percutaneous patent foramen ovale closure: A prospective study
par: Florence Leclercq, et autres
Publié: (2021)